Journal article icon

Journal article

Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.

Abstract:

IMPORTANCE: This observational study describes the efficacy and safety of rituximab in 5 patients with voltage-gated potassium channel (VGKC)-complex/leucine-rich, glioma-inactivated 1 (LGI1) antibody-associated encephalopathy. Rituximab is a monoclonal antibody that targets CD20 and is used to treat other neurologic and nonneurologic diseases. OBSERVATIONS: This case series reports sequential seizure frequencies, modified Rankin Scale scores, and VGKC-complex antibody titers in 5 adult patie...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1001/jamaneurol.2014.463

Authors


Journal:
JAMA neurology
Volume:
71
Issue:
7
Pages:
896-900
Publication date:
2014-07-05
DOI:
EISSN:
2168-6157
ISSN:
2168-6149
URN:
uuid:6038e93c-5dab-4506-9330-d33b95ed3253
Source identifiers:
465562
Local pid:
pubs:465562

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP